NASDAQ:MLYS | Cash Flow Statement | Mineralys Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$241.07M
2026-03-31-$39.34M$6,000.00-$39.47M-$44.94M$24.27M
2025-12-31-$32.23M$13,000.00-$37.89M-$103.49M$96.7M
2025-09-30-$36.93M
2025-06-30-$43.27M
2025-03-31-$42.21M$15,000.00-$45.49M-$92.88M$189.28M
2024-12-31-$48.95M$15,000.00-$66.84M$83.57M$90,000.00
2024-09-30-$56.34M
2024-06-30-$41.01M
2024-03-31-$31.51M$8,000.00-$19.14M-$55.95M$116.21M
2023-12-31-$24.39M$0.00-$28.98M-$8.09M$74,000.00
2023-09-30-$22.76M
2023-06-30-$12.14M
2023-03-31-$12.61M$0.00-$12.78M-$140.25M$203.57M
2022-12-31-$9.07M-$10.19M$50M-$1.07M
2022-09-30-$6.68M
2022-06-30-$6.48M
2022-03-31-$7.57M-$6.58M$0.00$12M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$154.65M$59,000.00-$142.42M-$389.75M$591M
2024-12-31-$177.81M$43,000.00-$166.31M$114.96M$116.14M
2023-12-31-$71.9M$0.00-$81.17M-$160.47M$203.25M
2022-12-31-$29.8M-$29.22M-$21.76M$128.02M